Literature DB >> 35915350

Effect of In Vitro Maturation of Human Oocytes Obtained After Controlled Ovarian Hormonal Stimulation on the Expression of Development- and Zona Pellucida-Related Genes and Their Interactions.

Jure Bedenk1, Tadeja Režen2, Nina Jančar3, Ksenija Geršak4, Irma Virant Klun5.   

Abstract

In an in vitro fertilization program, approximately 10-15% of oocytes obtained after controlled ovarian stimulation are immature, with germinal vesicles (GVs). These oocytes are usually discarded in clinical practice; however, an in vitro maturation (IVM) procedure can be applied to mature them. There are scarce data in the literature on the effect of IVM on the expression of important development- and zona pellucida (ZP)-related genes in human oocytes; therefore, we wanted to determine this. One hundred nine human oocytes were collected from patients enrolled in an intracytoplasmic sperm injection program. The expression of the BMP4, GDF9, ZP1, ZP2, ZP3, and ZP4 genes was analyzed using RT-qPCR in oocytes matured in vitro with different reproductive hormones in the IVM medium (AMH, FSH + hCG, FSH + hCG + AMH), in in vivo matured oocytes and in immature oocytes with GVs. No statistically significant differences in the expression of selected genes in oocytes were observed among groups with different reproductive hormones in IVM medium. However, several interesting significant correlations were found between BMP4 and GDF9, and ZP1 and ZP4; between GDF9 and ZP1, and ZP2 and ZP4; and between ZP1 and ZP3 and ZP4 in the in vitro matured oocytes, while no such correlations were present in other groups of oocytes. The type of reproductive hormone in the maturation medium does not affect the expression of the analyzed genes in oocytes during the maturation process. However, the in vitro maturation procedure itself generated correlations among analyzed genes that were otherwise not present in in vivo matured and immature oocytes.
© 2022. The Author(s), under exclusive licence to Society for Reproductive Investigation.

Entities:  

Keywords:  Development genes; Human oocyte; In vitro maturation; RT–qPCR; Time-lapse microscopy; Zona pellucida–related genes

Year:  2022        PMID: 35915350     DOI: 10.1007/s43032-022-01047-1

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  42 in total

Review 1.  Testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications.

Authors:  Nathalie Josso; Jean Yves Picard; Rodolfo Rey; Nathalie di Clemente
Journal:  Pediatr Endocrinol Rev       Date:  2006-06

Review 2.  AMH: An ovarian reserve biomarker in assisted reproduction.

Authors:  C Peluso; F L A Fonseca; I F Rodart; V Cavalcanti; G Gastaldo; D M Christofolini; C P Barbosa; B Bianco
Journal:  Clin Chim Acta       Date:  2014-07-30       Impact factor: 3.786

3.  Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.

Authors:  Anna Nyström; Helena Mörse; Hanna Nordlöf; Karin Wiebe; Maria Artman; Ingrid Øra; Aleksander Giwercman; Emir Henic; Maria Elfving
Journal:  Acta Oncol       Date:  2018-12-18       Impact factor: 4.089

4.  Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.

Authors:  M Š Alebic; N Stojanovic; D Dewailly
Journal:  Hum Reprod       Date:  2018-06-01       Impact factor: 6.918

5.  Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

Authors:  S Lie Fong; J A Visser; C K Welt; Y B de Rijke; M J C Eijkemans; F J Broekmans; E M Roes; W H M Peters; A C S Hokken-Koelega; B C J M Fauser; A P N Themmen; F H de Jong; I Schipper; J S E Laven
Journal:  J Clin Endocrinol Metab       Date:  2012-09-19       Impact factor: 5.958

6.  Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.

Authors:  Erik A H Knauff; Marinus J C Eijkemans; Cornelius B Lambalk; Marianne J ten Kate-Booij; Annemieke Hoek; Catharina C M Beerendonk; Joop S E Laven; Angelique J Goverde; Frank J M Broekmans; Axel P N Themmen; Frank H de Jong; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2008-12-09       Impact factor: 5.958

7.  Formation and early development of follicles in the polycystic ovary.

Authors:  L J Webber; S Stubbs; J Stark; G H Trew; R Margara; K Hardy; S Franks
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

8.  Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women's Study.

Authors:  Sangeeta Nair; James C Slaughter; James G Terry; Duke Appiah; Imo Ebong; Erica Wang; David S Siscovick; Barbara Sternfeld; Pamela J Schreiner; Cora E Lewis; Edmond K Kabagambe; Melissa F Wellons
Journal:  Maturitas       Date:  2015-06-16       Impact factor: 5.110

9.  The effect of serum and follicular fluid anti-Mullerian hormone level on the number of oocytes retrieved and rate of fertilization and clinical pregnancy.

Authors:  Seda Eymen Bolat; Safak Ozdemirci; Taner Kasapoglu; Bulent Duran; Levent Goktas; Ertugrul Karahanoglu
Journal:  North Clin Istanb       Date:  2016-11-25

10.  Recombinant anti-Müllerian hormone in the maturation medium improves the in vitro maturation of human immature (GV) oocytes after controlled ovarian hormonal stimulation.

Authors:  Jure Bedenk; Tadeja Režen; Taja Železnik Ramuta; Nina Jančar; Eda Vrtačnik Bokal; Ksenija Geršak; Irma Virant Klun
Journal:  Reprod Biol Endocrinol       Date:  2022-01-24       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.